How Does Microsatellite Instability Influence Cancer Treatment?
MSI status can significantly impact treatment decisions. For example, tumors with high levels of MSI (MSI-H) are often more responsive to immunotherapy with checkpoint inhibitors. Drugs like pembrolizumab and nivolumab have shown efficacy in treating MSI-H cancers by enhancing the immune system's ability to recognize and attack tumor cells.
